End-of-day quote
Korea S.E.
18:00:00 2024-05-02 EDT
|
5-day change
|
1st Jan Change
|
10,150
KRW
|
+3.57%
|
|
+5.40%
|
+19.27%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
---|
Capitalization
1 |
69,184
|
100,843
|
112,645
|
60,229
|
71,800
|
Enterprise Value (EV)
2 |
69.18
|
100.8
|
137.2
|
60.23
|
99.1
|
P/E ratio
|
-
|
-
|
10.6
x
|
9.83
x
|
8.13
x
|
Yield
|
-
|
-
|
0.43%
|
-
|
-
|
Capitalization / Revenue
|
1.46
x
|
1.97
x
|
1.78
x
|
-
|
0.81
x
|
EV / Revenue
|
1.46
x
|
1.97
x
|
2.17
x
|
-
|
1.12
x
|
EV / EBITDA
|
-
|
-
|
6.67
x
|
-
|
4.25
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
22
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
4.54%
|
Price to Book
|
-
|
-
|
1.61
x
|
-
|
0.82
x
|
Nbr of stocks (in thousands)
|
7,287
|
7,129
|
7,128
|
7,077
|
7,074
|
Reference price
3 |
9,495
|
14,145
|
15,803
|
8,510
|
10,150
|
Announcement Date
|
20-02-07
|
21-03-16
|
22-02-24
|
24-03-21
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
---|
Net sales
1 |
47.42
|
51.16
|
63.27
|
-
|
88.1
|
EBITDA
1 |
-
|
-
|
20.58
|
-
|
23.3
|
EBIT
1 |
7.213
|
11.3
|
11.06
|
-
|
11.5
|
Operating Margin
|
15.21%
|
22.08%
|
17.48%
|
-
|
13.05%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
10.88
|
-
|
10
|
Net income
1 |
-
|
-
|
10.44
|
7.368
|
9.1
|
Net margin
|
-
|
-
|
16.49%
|
-
|
10.33%
|
EPS
2 |
-
|
-
|
1,488
|
866.0
|
1,249
|
Free Cash Flow
3 |
-
|
-
|
-
|
-
|
4,500
|
FCF margin
|
-
|
-
|
-
|
-
|
5,107.83%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
19,313.3%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
49,450.55%
|
Dividend per Share
2 |
-
|
-
|
67.87
|
-
|
-
|
Announcement Date
|
20-02-07
|
21-03-16
|
22-02-24
|
24-03-21
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
---|
Net sales
1 |
16.54
|
16.45
|
17.09
|
16.64
|
17.53
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
3.169
|
1.411
|
-
|
1.479
|
1.899
|
Operating Margin
|
19.16%
|
8.58%
|
-
|
8.89%
|
10.83%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
2.904
|
-
|
-
|
Net margin
|
-
|
-
|
16.99%
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-05
|
22-02-24
|
22-04-26
|
22-08-09
|
22-11-14
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
---|
Net Debt
1 |
-
|
-
|
24.6
|
-
|
27.3
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.195
x
|
-
|
1.172
x
|
Free Cash Flow
2 |
-
|
-
|
-
|
-
|
4,500
|
ROE (net income / shareholders' equity)
|
12.8%
|
-
|
16.4%
|
-
|
10.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
10.2%
|
-
|
6%
|
Assets
1 |
-
|
-
|
102.4
|
-
|
151.7
|
Book Value Per Share
3 |
-
|
-
|
9,806
|
-
|
12,434
|
Cash Flow per Share
|
-
|
-
|
2,021
|
-
|
-
|
Capex
1 |
-
|
-
|
33.4
|
-
|
13
|
Capex / Sales
|
-
|
-
|
52.81%
|
-
|
14.76%
|
Announcement Date
|
20-02-07
|
21-03-16
|
22-02-24
|
24-03-21
|
-
|
1KRW in Billions2KRW in Million3KRW |
1st Jan change
|
Capi.
|
---|
| +19.27% | 53M | | +13.54% | 17.23B | | 0.00% | 7.08B | | -11.41% | 2.91B | | -6.89% | 2.85B | | -27.64% | 1.83B | | -2.47% | 1.16B | | -6.63% | 1.07B | | -10.95% | 831M | | +0.83% | 767M |
Testing Laboratories
|